Hudson Edge Investment Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
126,604
+12,925
+11% +$144K 0.18% 65
2026
Q1
$1.35M Buy
113,679
+52,043
+84% +$533K 0.2% 59
2025
Q4
$614K Buy
+61,636
New +$589K 0.09% 80
2024
Q4
Sell
-8,261
Closed -$92.8K 189
2024
Q3
$92.8K Hold
8,261
0.02% 159
2024
Q2
$82.6K Sell
8,261
-1,916
-19% -$19.5K 0.02% 157
2024
Q1
$117K Buy
+10,177
New +$86.4K 0.02% 153
2023
Q3
Sell
-20,048
Closed -$244K 131
2023
Q2
$244K Buy
+20,048
New +$223K 0.08% 120

Other funds holding AHCO

Hudson Edge Investment Partners's AHCO Position: Q2 2026 in Review

Hudson Edge Investment Partners increased its AdaptHealth (AHCO) stake by 11% in Q2 2026, buying an estimated $144K and bringing the position to 126,604 shares worth $1.32M. The position accounts for 0.18% of the portfolio, ranked #65.

Hudson Edge Investment Partners first reported a position in AHCO in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.35M in Q1 2026. 47 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Hudson Edge Investment Partners held 126,604 shares of AdaptHealth worth $1.32M as of Q2 2026.
  • Hudson Edge Investment Partners bought 12,925 AdaptHealth shares in Q2 2026, an estimated $144K.
  • AdaptHealth made up 0.18% of Hudson Edge Investment Partners's portfolio in Q2 2026, its #65 holding.
  • Hudson Edge Investment Partners first reported a position in AdaptHealth in Q2 2023 and has held it in 7 quarters since.
  • Hudson Edge Investment Partners's AdaptHealth position peaked at $1.35M in Q1 2026.
  • 47 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Hudson Edge Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.